search
Back to results

Building an Outcomes Assessment Infrastructure to Assess Anxiety Treatment

Primary Purpose

Social Anxiety Disorder, Specific Phobia, Separation Anxiety Disorder

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
McLean Anxiety Mastery Program
Sponsored by
Mclean Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Social Anxiety Disorder

Eligibility Criteria

6 Years - 19 Years (Child, Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • All youth who are eligible to participate in the McLean Anxiety Mastery Program will be invited to participate in the research study.
  • Eligibility criteria for the McLean Anxiety Mastery Program include:

    • children and adolescents who are between the ages of 6 and 19 and
    • who present with at least one of the following disorders:

      • Separation Anxiety Disorder,
      • Social Anxiety Disorder,
      • Panic Disorder,
      • Agoraphobia,
      • Specific Phobia(s), and
      • OCD.
    • Interested and eligible patients and their caregivers should complete and submit an application (https://www.mcleanhospital.org/sites/default/files/2021-07/MAMP-Application-07032021_0.pdf) to begin the phone screen process.

Exclusion Criteria:

  • Patients ineligible for the treatment program, and therefore the study, include those who have engaged in substance abuse during the six weeks prior to the first evaluation (i.e., waitlist or admission) the phone screening,
  • those who report that they are unwilling to refrain from self-injurious behaviors during the waitlist and treatment periods,
  • those who are experiencing active symptoms of psychosis,
  • those who exhibit severe behavioral disinhibition or aggression, and
  • those who express an intent and/or plan to commit suicide or homicide at the time of their first evaluation the initial phone screening.
  • Patients must be fluent in English to participate in the program because all off-grounds exposure groups will be conducted in English (whenever possible, however, translation services will be provided for patients whose parents are not fluent in English).

Sites / Locations

  • McLean HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Treatment (Cognitive-Behavioral Therapy)

Waitlist

Arm Description

Participants in the McLean Anxiety Mastery Program

Participants on the waitlist for the McLean Anxiety Mastery Program

Outcomes

Primary Outcome Measures

Change in Score in Spence Children's Anxiety Scale (SCAS; Spence 1997).
The SCAS is a 44-item self-report inventory that measures anxiety severity.

Secondary Outcome Measures

Change in Score in Center for Epidemiolgic Studies Depression Scale (CES-D; Radloff 1977).
The CES-D is a 20-item self-report inventory that measures depression severity.

Full Information

First Posted
November 14, 2014
Last Updated
March 13, 2023
Sponsor
Mclean Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT02305537
Brief Title
Building an Outcomes Assessment Infrastructure to Assess Anxiety Treatment
Official Title
Building an Outcomes Assessment Infrastructure to Assess Youth in the McLean Anxiety Mastery Program at McLean Hospital
Study Type
Interventional

2. Study Status

Record Verification Date
March 2023
Overall Recruitment Status
Recruiting
Study Start Date
October 2014 (Actual)
Primary Completion Date
October 2050 (Anticipated)
Study Completion Date
October 2070 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Mclean Hospital

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The collection of patient self-report and diagnostic data will allow us to examine the efficacy of the treatment delivered in the McLean Anxiety Mastery Program. Using data gathered through routine clinical care, the investigators seek to explore whether patients in treatment show improvements from admission to discharge, compared to patients on the waitlist, and whether these gains are maintained three months post-discharge. The following are included as examples of some of the study's hypotheses.
Detailed Description
The study population will involve all assenting/consenting patients, both male and female, admitted to the McLean Anxiety Mastery Program at McLean Hospital. This program provides intensive group-based treatment for anxious youth (aged 6-19). Patients in the McLean Anxiety Mastery Program participate in a minimum of four weeks of treatment and attend the program for four days per week. Three days per week, patients attend group-based treatment for two-and-a-half hours per day. The fourth day of each week consists of a one-hour group-based treatment, a one-hour family meeting, and a one-hour exposure session that includes children and their caregivers. One day per week, parents also attend a one-hour parent guidance group as part of the overall treatment package. Patients also have psychopharmacology consultations with the program psychiatrist on a case-by-case basis. On their first birthday that falls after the date of discharge, patients are sent a birthday card that includes a greeting and reminders about coping skills that they learned in the program. The investigators expect to recruit at least 45 assenting/consenting patients in the first year of the study. The plan is to treat six-to-eight patients during each one-month module and to have a waitlist, if interest in the program exceeds the program's capacity. If a waitlist exists, patients, who are on this waitlist, will be evaluated as the study's control group once they are four weeks away from their target admission date. Before the patient's first assessment through the program, a clinician will inform the patient and caregivers about the opportunity to participate in a voluntary research study at the McLean Anxiety Mastery Program. Assent/consent will be requested to utilize these data for research purposes. The patient and caregivers will be told that all of the information gathered from the child- and caregiver-report measures are part of routine clinical practice, and permission is being sought to use this de-identified data for research purposes. The patient and caregivers will be reminded that their decision to or not to participate in the research study will not affect the treatment they receive. The assessments are conducted at the following time points: 1) upon admission, 2) weekly while the patients are participating in treatment, 3) upon discharge, and 4) at a three-month follow-up visit. The child- and parent--report questionnaires are administered through REDCap Survey, a secure, HIPAA-compliant program for building and managing online surveys. The measures are completed on families' devices at home. If a patient or family member does not complete the online survey within 48 hours, a clinician will contact them with a reminder one time via phone or e-mail. The survey does not include questions assessing risk (e.g., for suicidal ideation, self-harm, substance use).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Social Anxiety Disorder, Specific Phobia, Separation Anxiety Disorder, Panic Disorder, Agoraphobia, Obsessive-Compulsive Disorder

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Non-Randomized
Enrollment
45 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Treatment (Cognitive-Behavioral Therapy)
Arm Type
Experimental
Arm Description
Participants in the McLean Anxiety Mastery Program
Arm Title
Waitlist
Arm Type
No Intervention
Arm Description
Participants on the waitlist for the McLean Anxiety Mastery Program
Intervention Type
Behavioral
Intervention Name(s)
McLean Anxiety Mastery Program
Intervention Description
Cognitive-Behavioral Therapy with Exposure and Response Prevention
Primary Outcome Measure Information:
Title
Change in Score in Spence Children's Anxiety Scale (SCAS; Spence 1997).
Description
The SCAS is a 44-item self-report inventory that measures anxiety severity.
Time Frame
Change between 0 weeks of treatment and after weeks of treatment, change between 4 weeks of treatment and 16 weeks after treatment
Secondary Outcome Measure Information:
Title
Change in Score in Center for Epidemiolgic Studies Depression Scale (CES-D; Radloff 1977).
Description
The CES-D is a 20-item self-report inventory that measures depression severity.
Time Frame
Change between 0 weeks of treatment and after weeks of treatment, change between 4 weeks of treatment and 16 weeks after treatment
Other Pre-specified Outcome Measures:
Title
Change in Score in Spence Children's Anxiety Scale (SCAS - Parent Report; Spence 2000).
Description
The SCAS -Parent Report is a 39-item parent report inventory that measures the child's anxiety severity.
Time Frame
Change between 0 weeks of treatment and after weeks of treatment, change between 4 weeks of treatment and 16 weeks after treatment

10. Eligibility

Sex
All
Minimum Age & Unit of Time
6 Years
Maximum Age & Unit of Time
19 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: All youth who are eligible to participate in the McLean Anxiety Mastery Program will be invited to participate in the research study. Eligibility criteria for the McLean Anxiety Mastery Program include: children and adolescents who are between the ages of 6 and 19 and who present with at least one of the following disorders: Separation Anxiety Disorder, Social Anxiety Disorder, Panic Disorder, Agoraphobia, Specific Phobia(s), and OCD. Interested and eligible patients and their caregivers should complete and submit an application (https://www.mcleanhospital.org/sites/default/files/2021-07/MAMP-Application-07032021_0.pdf) to begin the phone screen process. Exclusion Criteria: Patients ineligible for the treatment program, and therefore the study, include those who have engaged in substance abuse during the six weeks prior to the first evaluation (i.e., waitlist or admission) the phone screening, those who report that they are unwilling to refrain from self-injurious behaviors during the waitlist and treatment periods, those who are experiencing active symptoms of psychosis, those who exhibit severe behavioral disinhibition or aggression, and those who express an intent and/or plan to commit suicide or homicide at the time of their first evaluation the initial phone screening. Patients must be fluent in English to participate in the program because all off-grounds exposure groups will be conducted in English (whenever possible, however, translation services will be provided for patients whose parents are not fluent in English).
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jacqueline Sperling, Ph.D.
Organizational Affiliation
Mclean Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
McLean Hospital
City
Cambridge
State/Province
Massachusetts
ZIP/Postal Code
02138
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jacqueline Sperling, Ph.D.
Phone
617-674-5335
Email
jsperling@mclean.harvard.edu
First Name & Middle Initial & Last Name & Degree
Jacqueline Sperling, Ph.D.

12. IPD Sharing Statement

Learn more about this trial

Building an Outcomes Assessment Infrastructure to Assess Anxiety Treatment

We'll reach out to this number within 24 hrs